Inaugural Meeting of the U.S.-India Drug Policy Executive Working Group

From January 20–21, 2026, the United States and India held the inaugural meeting of the U.S.-India Drug Policy Executive Working Group in Washington, D.C. The meeting aimed to fulfill a mutual commitment between President Trump and Prime Minister Modi to strengthen security cooperation and eradicate narco-terrorism. Key Highlights of the Meeting: National Security Priority: ONDCP Director Sara Carter characterized the drug crisis as a "core national security priority," emphasizing the need to protect families while supporting legitimate industry. Targeting Trafficking: The delegations focused on dismantling the illegal production and trafficking of illicit drugs and the diversion of precursor chemicals. Pharmaceutical Supply Chain: Both nations emphasized securing the pharmaceutical supply chain and balancing strict law enforcement with the facilitation of legitimate trade. Whole-of-Government Approach: The working group committed to a streamlined, interagency effort to disrupt illicit networks, building on the success of recent joint operations. Leadership: The discussions were led by the U.S. Office of National Drug Control Policy (ONDCP) and India’s Narcotics Control Bureau (NCB), with participation from Indian Ambassador Vinay Kwatra. Conclusion: The inaugural meeting marks a significant step in the enduring counter-narcotics partnership between the U.S. and India, aimed at fostering a safer and healthier future through disciplined, bilateral execution.